Credit Suisse First Boston Equity Partners, L.p. - Net Worth and Insider Trading

Credit Suisse First Boston Equity Partners, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Credit Suisse First Boston Equity Partners, L.p. owns 3 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , Cytokinetics Inc (CYTK) , and Viracta Therapeutics Inc (VIRX) .

Click here to see the complete history of Credit Suisse First Boston Equity Partners, L.p.’s form 4 insider trades.

Insider Ownership Summary of Credit Suisse First Boston Equity Partners, L.p.

Ticker Comapny Transaction Date Type of Owner
SNSS Sunesis Pharmaceuticals Inc 2005-09-30 10 percent owner
CYTK Cytokinetics Inc 2004-04-29 10 percent owner
VIRX Viracta Therapeutics Inc 2005-09-30 10 percent owner

Credit Suisse First Boston Equity Partners, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Credit Suisse First Boston Equity Partners, L.p. Ownership Network

Ownership Network List of Credit Suisse First Boston Equity Partners, L.p.

No Data

Ownership Network Relation of Credit Suisse First Boston Equity Partners, L.p.

Insider Network Chart

Credit Suisse First Boston Equity Partners, L.p. Owned Company Details

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Credit Suisse First Boston Equity Partners, L.p. is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

Credit Suisse First Boston Equity Partners, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Credit Suisse First Boston Equity Partners, L.p.. You might contact Credit Suisse First Boston Equity Partners, L.p. via mailing address: 11 Madison Avenue, New York Ny 10010.